Pediatric Pharmacoepidemiology

(B-235) Acid-Suppressive Medications and Risk of Childhood Asthma: A Meta-Analysis of Observational Epidemiological Studies

(B-243) Adverse Drug Events (ADEs) Associated with Outpatient Antibiotic Fills to Children by Dentists, 2014-2019

(B-232) Antipsychotic use in youth and children: a cohort study from Catalonia (Spain) of treatment patterns

(B-236) Correlation of Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA) carriage in caregiver and children.

(B-242) Identification of Infant Congenital Malformations in a Large US Insurance Claims Database

(B-234) Impact of Three Antimalarial Therapies on Renal Function in Nigerian Children with Uncomplicated Plasmodium Falciparum Infection

(B-239) Incidence of post-partum hemorrhage and amount of blood loss in the Netherlands

(B-241) Prevalence of Adolescent Drug Overdose by Drug Involvement and Intent in U.S. Medicaid, 2016-2020

(B-237) Risk factors for Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA) carriage in children: a case-control study

(B-238) Risk Prediction Models for Adverse Drug Reactions in Pediatric Patients: A Systematic Review

(B-240) Treatment-Resistant Depression (TRD) in Children and Adolescents and its Life-Course Determinants

(B-233) Trends in Utilization of Chronic Asthma Medications among Publicly Insured Children in the US: 2003 to 2020